149 related articles for article (PubMed ID: 23352614)
1. PTK6 promotes degradation of c-Cbl through PTK6-mediated phosphorylation.
Kang SA; Lee ST
Biochem Biophys Res Commun; 2013 Feb; 431(4):734-9. PubMed ID: 23352614
[TBL] [Abstract][Full Text] [Related]
2. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
3. PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.
Shin WS; Shim HJ; Lee YH; Pyo M; Park JS; Ahn SY; Lee ST
J Cell Biochem; 2017 Sep; 118(9):2887-2895. PubMed ID: 28214294
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion.
Pires IM; Blokland NJ; Broos AW; Poujade FA; Senra JM; Eccles SA; Span PN; Harvey AJ; Hammond EM
Cancer Biol Ther; 2014 Oct; 15(10):1350-7. PubMed ID: 25019382
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
6. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
[TBL] [Abstract][Full Text] [Related]
9. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.
Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194
[TBL] [Abstract][Full Text] [Related]
10. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
11. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
12. Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation.
Howlett CJ; Robbins SM
Oncogene; 2002 Mar; 21(11):1707-16. PubMed ID: 11896602
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
14. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
[TBL] [Abstract][Full Text] [Related]
15. c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
Wiggins CM; Band H; Cook SJ
Cell Signal; 2007 Dec; 19(12):2605-11. PubMed ID: 17884340
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
Masson K; Heiss E; Band H; Rönnstrand L
Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
[TBL] [Abstract][Full Text] [Related]
17. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
Zheng Y; Asara JM; Tyner AL
J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
[TBL] [Abstract][Full Text] [Related]
19. [Implication of the ubiquitin ligase c-Cbl in bone formation and tumorigenesis].
Sévère N; Marie P
Med Sci (Paris); 2012 Nov; 28(11):970-5. PubMed ID: 23171901
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
